The Biopharma business of Merck, is pursuing activities in selected indications for highly specialized therapeutic areas mainly treated by specialists. The portfolio includes leading biopharmaceutical drugs that benefit patients who suffer from colorectal cancer, head and neck tumors or multiple sclerosis. In addition, the business offers therapies to treat infertility, growth disorders, cardiovascular diseases, diabetes and thyroid diseases.